Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07351305 · ClinicalTrials.gov registry record · NA

Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI

A NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07351305: Recruiting NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by The University of Texas Health Science Center at San Antonio.

NCT07351305 is a NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 30 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07351305, a NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The investigators want to test a treatment for posttraumatic stress disorder (PTSD) especially designed for military veterans and service members with mild or moderate traumatic brain injuries (TBI) and PTSD. The treatment will include individual psychotherapy sessions to manage PTSD.

Primary Outcome

The PCL-5 is a 20-item self-report measure designed to assess PTSD symptoms as defined by the DSM-5. The scoring involves summing the responses to 20 items (0 to 80) with higher scores indicating more severe PTSD.

Conditions Studied

Post Traumatic Stress Disorder Traumatic Brain Injury PTSD

Interventions

  • BEHAVIORAL Non-Trauma Treatment for TBI and PTSD

Study Locations (1)

Texas

  • Carl R Darnall Army Medical Center - Fort Hood

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-03-05
Est. Completion 2027-08
Phase NA
The University of Texas Health Science Center at San Antonio

378 total trials

What NCT07351305 shows while recruiting

NCT07351305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Non-Trauma Treatment for TBI and PTSD is the first listed.

NCT07351305 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07351305 about?

NCT07351305 is a clinical study titled "Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI". The investigators want to test a treatment for posttraumatic stress disorder (PTSD) especially designed for military veterans and service members with mild or moderate traumatic brain injuries (TBI) and PTSD. The treatment will include individual psychotherapy sessions to manage PTSD.

What is the current status of trial NCT07351305?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03-05. Estimated completion is 2027-08.

What conditions does trial NCT07351305 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury, PTSD.

What interventions are being tested in trial NCT07351305?

The interventions under investigation include: Non-Trauma Treatment for TBI and PTSD (BEHAVIORAL).

Who is sponsoring clinical trial NCT07351305?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07351305 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07351305's enrollment target sits among peer trials

30 210th of 262 higher than 44 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07351305

Source: ClinicalTrials.gov NCT07351305, the US trial registry maintained by the National Library of Medicine. NCT07351305 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.